Translation of Molecular Pathways into Clinical Trials of Neuroendocrine Tumors

Neuroendocrinology, 04/13/2012

Pavel M – The review provides a broad overview of established and potential molecular targets in neuroendocrine tumors (NET), summarizes data from phase II and III clinical trials with targeted drugs and outlines future therapeutic directions.

Print Article Summary Cat 2 CME Report